Douglas Fambrough | Co-Founder, CEO, President |
John Green | CFO |
Ralf Rosskamp | Chief Medical Officer |
Bob Brown | Chief Scientific Officer |
Jonathan Miller | Evercore |
Prakhar Verma | Stifel |
Ritu Baral | Cowen |
Ed Arce | H.C. Wainwright & Company |
Keay Nakae | Chardan |
Madhu Kumar | B. Riley |
Good day, ladies and gentlemen, and welcome to the Dicerna Pharmaceuticals Q1 2018 Earnings Conference Call. At this time all participants are in a listen-only mode. Later we will conduct a question-and-answer session and instructions will follow at that time. [Operator Instructions] As a reminder, this conference call is being recorded. I would now like to introduce your host for today's conference, Mr.